Robin Shane Readnour

ANTX

Robin Shane Readnour serves as Director at AN2 Therapeutics, Inc. (ANTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$2.65M

Total Sells

2 trades

$111.7K

Net Position

Net Buyer

$2.53M

Companies Traded

ANTX

Active Period

Mar 2022 – Dec 2024

6 total trades

Most Recent

Buy ANTX

Dec 6, 2024 · $79.2K

Robin Shane Readnour's Insider Trading at AN2 Therapeutics, Inc. (ANTX)

Buys

4 · $2.65M

Sells

2 · $111.7K

Total Shares Bought

445,834

Total Shares Sold

5,094

ANTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 6, 2024	Buy	55,000	$1.44	$79.2K
Nov 26, 2024	Buy	37,500	$1.41	$52.8K
Nov 19, 2024	Buy	200,000	$1.07	$213.1K
Jan 12, 2024	Sell	1,425	$21.91	$31.2K
Jan 10, 2024	Sell	3,669	$21.93	$80.4K
Mar 29, 2022	Buy	153,334	$15.00	$2.30M